Cell Culture Media Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The global cell culture media market is set to experience unprecedented growth, with worldwide revenue reaching US$ 3.6 billion in 2024. By the end of 2031, the market is anticipated to reach a valuation of US$ 6 billion, driven by a myriad of factors reshaping the landscape of cell culture and biopharmaceutical industries.

Fueling Scientific Progress

Cell culture, the in-vitro process of harvesting cells, relies on nutrient-rich media and a sterile environment to support cell growth. Amino acids, glucose, inorganic salts, and serum constitute the essential components of cell culture media, enabling scientific advancements in disease treatments and research.

Driving Forces of Market Growth

Regenerative Medicine: The development of regenerative medicines that utilize tissue grafts created with cell culture media is on the rise, contributing to the market's expansion. Tissue engineering has advanced significantly, allowing for the creation of various tissues in a laboratory setting, bolstering disease treatments and research funding.

Antibody Production: The market is expected to grow as the production of monoclonal antibodies using cell culture media increases. This technology has proven to be reliable and effective, with a wide range of applications, including the treatment of autoimmune diseases, driving market expansion.

Cost-Effective Solutions: The introduction of cost-effective cell culture media, particularly serum-free variants, is poised to fuel market growth. Affordable media manufacturing methods are anticipated to lead to widespread adoption.

Challenges and Considerations

High R&D Costs: The high cost of research and development operations poses a significant challenge to market expansion. Precise ingredient ratios and skilled personnel are essential, driving up the price of media.

Sterility Concerns: Ensuring the sterility of cell culture media is critical but challenging, as various cell types may become contaminated. Contamination risks are significant in the lab setting, potentially slowing market growth.

Country-Wise Insights

United States: The U.S. market boasts a substantial share in North America, driven by the burgeoning biotechnology and pharmaceutical industries, increased investments in cell-based research, regulatory approvals for cell culture-based vaccines, and robust government support.

Germany: Partnerships between manufacturers and government associations, coupled with a thriving European biopharmaceutical industry, government initiatives supporting research, and increased healthcare spending, are fueling the cell culture media market in Germany.

China: With a rising incidence of cancer and substantial investments in research, China is emerging as a prominent market. Low labor and manufacturing costs, expanding healthcare infrastructure, and international market leaders' investments further contribute to China's growth in the sector.

Competitive Landscape

Leading manufacturers are enhancing their product ranges with effective media cultures, often through mergers and acquisitions. Company partnerships aimed at improving cell culture media for chemotherapeutic research are also driving innovation and market competitiveness.

Key Companies in the Market

Becton, Dickinson and Company
Hi-Media Laboratories
Merck, KGaA
STEMCELL Technologies Inc.
Cell Sciences, Inc.
GE Healthcare
PAN Biotech
MP Biomedicals, LLC.
PromCell GmbH
Irvine Scientific
Lonza
Corning Incorporated

Segments of Cell Culture Media Industry Research

By Product:

Serum Containing Media
Serum Free Media
- Protein Expression Media
- Stem Cell Media
- Hybridoma Media
- Primary Cell Media
- Insect Cell Media
- Immunology Media
- CHO Cell Culture Media

Protein Free Media
Chemically Defined Media

By Application:

Cancer Research
Biopharmaceuticals
Regenerative Medicine & Tissue Engineering
Stem Cell Technologies
Others

By End User:

Biopharmaceutical Companies
Clinical Research Organizations
Academic Research Centers

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

1. Executive Summary

1.1. Global Cell Culture Media Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Cell Culture Media Market Outlook, 2018 - 2031

3.1. Global Cell Culture Media Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Serum Containing Media
  - 3.1.1.2. Serum Free Media
    - 3.1.1.2.1. Protein Expression Media
    - 3.1.1.2.2. Stem Cell Media
    - 3.1.1.2.3. Hybridoma Media
    - 3.1.1.2.4. Primary Cell Media
    - 3.1.1.2.5. Insect Cell Media
    - 3.1.1.2.6. Immunology Media
    - 3.1.1.2.7. CHO Cell Culture Media
  - 3.1.1.3. Protein Free Media
  - 3.1.1.4. Chemically Defined Media
3.2. Global Cell Culture Media Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Cancer Research
  - 3.2.1.2. Biopharmaceuticals
  - 3.2.1.3. Regenerative Medicine & Tissue Engineering
  - 3.2.1.4. Stem Cell Technologies
  - 3.2.1.5. Others
3.3. Global Cell Culture Media Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Biopharmaceutical Companies
  - 3.3.1.2. Clinical Research Organizations
  - 3.3.1.3. Academic Research Centers
- 3.3.2. BPS Analysis/Market Attractiveness Analysis
3.4. Global Cell Culture Media Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. North America
  - 3.4.1.2. Europe
  - 3.4.1.3. Asia Pacific
  - 3.4.1.4. Latin America
  - 3.4.1.5. Middle East & Africa

4. North America Cell Culture Media Market Outlook, 2018 - 2031

4.1. North America Cell Culture Media Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Serum Containing Media
  - 4.1.1.2. Serum Free Media
    - 4.1.1.2.1. Protein Expression Media
    - 4.1.1.2.2. Stem Cell Media
    - 4.1.1.2.3. Hybridoma Media
    - 4.1.1.2.4. Primary Cell Media
    - 4.1.1.2.5. Insect Cell Media
    - 4.1.1.2.6. Immunology Media
    - 4.1.1.2.7. CHO Cell Culture Media
  - 4.1.1.3. Protein Free Media
  - 4.1.1.4. Chemically Defined Media
4.2. North America Cell Culture Media Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Cancer Research
  - 4.2.1.2. Biopharmaceuticals
  - 4.2.1.3. Regenerative Medicine & Tissue Engineering
  - 4.2.1.4. Stem Cell Technologies
  - 4.2.1.5. Others
4.3. North America Cell Culture Media Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Biopharmaceutical Companies
  - 4.3.1.2. Clinical Research Organizations
  - 4.3.1.3. Academic Research Centers
- 4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Cell Culture Media Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. U.S. Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 4.4.1.2. U.S. Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.4.1.3. U.S. Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
  - 4.4.1.4. Canada Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 4.4.1.5. Canada Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.4.1.6. Canada Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
- 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Cell Culture Media Market Outlook, 2018 - 2031

5.1. Europe Cell Culture Media Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Serum Containing Media
  - 5.1.1.2. Serum Free Media
    - 5.1.1.2.1. Protein Expression Media
    - 5.1.1.2.2. Stem Cell Media
    - 5.1.1.2.3. Hybridoma Media
    - 5.1.1.2.4. Primary Cell Media
    - 5.1.1.2.5. Insect Cell Media
    - 5.1.1.2.6. Immunology Media
    - 5.1.1.2.7. CHO Cell Culture Media
  - 5.1.1.3. Protein Free Media
  - 5.1.1.4. Chemically Defined Media
5.2. Europe Cell Culture Media Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Cancer Research
  - 5.2.1.2. Biopharmaceuticals
  - 5.2.1.3. Regenerative Medicine & Tissue Engineering
  - 5.2.1.4. Stem Cell Technologies
  - 5.2.1.5. Others
5.3. Europe Cell Culture Media Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Biopharmaceutical Companies
  - 5.3.1.2. Clinical Research Organizations
  - 5.3.1.3. Academic Research Centers
- 5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Cell Culture Media Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Germany Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.4.1.2. Germany Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.3. Germany Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.4. U.K. Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.4.1.5. U.K. Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.6. U.K. Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.7. France Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.4.1.8. France Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.9. France Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.10. Italy Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.4.1.11. Italy Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.12. Italy Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.13. Turkey Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.4.1.14. Turkey Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.15. Turkey Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.16. Russia Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.4.1.17. Russia Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.18. Russia Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.19. Rest of Europe Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.4.1.20. Rest of Europe Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.21. Rest of Europe Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
- 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Cell Culture Media Market Outlook, 2018 - 2031

6.1. Asia Pacific Cell Culture Media Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Serum Containing Media
  - 6.1.1.2. Serum Free Media
    - 6.1.1.2.1. Protein Expression Media
    - 6.1.1.2.2. Stem Cell Media
    - 6.1.1.2.3. Hybridoma Media
    - 6.1.1.2.4. Primary Cell Media
    - 6.1.1.2.5. Insect Cell Media
    - 6.1.1.2.6. Immunology Media
    - 6.1.1.2.7. CHO Cell Culture Media
  - 6.1.1.3. Protein Free Media
  - 6.1.1.4. Chemically Defined Media
6.2. Asia Pacific Cell Culture Media Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Cancer Research
  - 6.2.1.2. Biopharmaceuticals
  - 6.2.1.3. Regenerative Medicine & Tissue Engineering
  - 6.2.1.4. Stem Cell Technologies
  - 6.2.1.5. Others
6.3. Asia Pacific Cell Culture Media Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Biopharmaceutical Companies
  - 6.3.1.2. Clinical Research Organizations
  - 6.3.1.3. Academic Research Centers
- 6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Cell Culture Media Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. China Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.4.1.2. China Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.3. China Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.4. Japan Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.4.1.5. Japan Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.6. Japan Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.7. South Korea Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.4.1.8. South Korea Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.9. South Korea Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.10. India Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.4.1.11. India Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.12. India Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.13. Southeast Asia Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.4.1.14. Southeast Asia Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.15. Southeast Asia Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.16. Rest of Asia Pacific Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.4.1.17. Rest of Asia Pacific Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.18. Rest of Asia Pacific Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Cell Culture Media Market Outlook, 2018 - 2031

7.1. Latin America Cell Culture Media Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Serum Containing Media
  - 7.1.1.2. Serum Free Media
    - 7.1.1.2.1. Protein Expression Media
    - 7.1.1.2.2. Stem Cell Media
    - 7.1.1.2.3. Hybridoma Media
    - 7.1.1.2.4. Primary Cell Media
    - 7.1.1.2.5. Insect Cell Media
    - 7.1.1.2.6. Immunology Media
    - 7.1.1.2.7. CHO Cell Culture Media
  - 7.1.1.3. Protein Free Media
  - 7.1.1.4. Chemically Defined Media
7.2. Latin America Cell Culture Media Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
7.3. Latin America Cell Culture Media Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Biopharmaceutical Companies
  - 7.3.1.2. Clinical Research Organizations
  - 7.3.1.3. Academic Research Centers
- 7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Cell Culture Media Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Brazil Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 7.4.1.2. Brazil Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.3. Brazil Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.4.1.4. Mexico Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 7.4.1.5. Mexico Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.6. Mexico Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.4.1.7. Argentina Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 7.4.1.8. Argentina Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.9. Argentina Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.4.1.10. Rest of Latin America Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 7.4.1.11. Rest of Latin America Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.12. Rest of Latin America Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Cell Culture Media Market Outlook, 2018 - 2031

8.1. Middle East & Africa Cell Culture Media Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Serum Containing Media
  - 8.1.1.2. Serum Free Media
    - 8.1.1.2.1. Protein Expression Media
    - 8.1.1.2.2. Stem Cell Media
    - 8.1.1.2.3. Hybridoma Media
    - 8.1.1.2.4. Primary Cell Media
    - 8.1.1.2.5. Insect Cell Media
    - 8.1.1.2.6. Immunology Media
    - 8.1.1.2.7. CHO Cell Culture Media
  - 8.1.1.3. Protein Free Media
  - 8.1.1.4. Chemically Defined Media
8.2. Middle East & Africa Cell Culture Media Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Cancer Research
  - 8.2.1.2. Biopharmaceuticals
  - 8.2.1.3. Regenerative Medicine & Tissue Engineering
  - 8.2.1.4. Stem Cell Technologies
  - 8.2.1.5. Others
8.3. Middle East & Africa Cell Culture Media Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Biopharmaceutical Companies
  - 8.3.1.2. Clinical Research Organizations
  - 8.3.1.3. Academic Research Centers
- 8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Cell Culture Media Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. GCC Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.4.1.2. GCC Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.3. GCC Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.4.1.4. South Africa Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.4.1.5. South Africa Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.6. South Africa Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.4.1.7. Egypt Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.4.1.8. Egypt Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.9. Egypt Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.4.1.10. Nigeria Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.4.1.11. Nigeria Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.12. Nigeria Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.4.1.13. Rest of Middle East & Africa Cell Culture Media Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.4.1.14. Rest of Middle East & Africa Cell Culture Media Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.15. Rest of Middle East & Africa Cell Culture Media Market by End User, Value (US$ Bn), 2018 - 2031
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. By Segment 3 vs by Application Heat map
9.2. Manufacturer vs by Application Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Becton, Dickinson and Company
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Hi-Media Laboratories
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. Merck, KGaA
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. STEMCELL Technologies Inc.
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Cell Sciences, Inc.
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. GE Healthcare
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. PAN Biotech
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. MP Biomedicals, LLC.
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development
- 9.5.9. PromCell GmbH
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development
- 9.5.10. Irvine Scientific
  - 9.5.10.1. Company Overview
  - 9.5.10.2. Product Portfolio
  - 9.5.10.3. Financial Overview
  - 9.5.10.4. Business Strategies and Development
- 9.5.11. Lonza
  - 9.5.11.1. Company Overview
  - 9.5.11.2. Product Portfolio
  - 9.5.11.3. Financial Overview
  - 9.5.11.4. Business Strategies and Development
- 9.5.12. Corning Incorporated
  - 9.5.12.1. Company Overview
  - 9.5.12.2. Product Portfolio
  - 9.5.12.3. Financial Overview
  - 9.5.12.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations